GB9811598D0 - Diagnosis and treatment of cancer - Google Patents
Diagnosis and treatment of cancerInfo
- Publication number
- GB9811598D0 GB9811598D0 GBGB9811598.3A GB9811598A GB9811598D0 GB 9811598 D0 GB9811598 D0 GB 9811598D0 GB 9811598 A GB9811598 A GB 9811598A GB 9811598 D0 GB9811598 D0 GB 9811598D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diagnosis
- cancer
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811598.3A GB9811598D0 (en) | 1998-05-30 | 1998-05-30 | Diagnosis and treatment of cancer |
| PCT/GB1999/001720 WO1999063110A1 (en) | 1998-05-30 | 1999-06-01 | Diagnosis and treatment of cancer |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9811598.3A GB9811598D0 (en) | 1998-05-30 | 1998-05-30 | Diagnosis and treatment of cancer |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB9811598D0 true GB9811598D0 (en) | 1998-07-29 |
Family
ID=10832928
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GBGB9811598.3A Ceased GB9811598D0 (en) | 1998-05-30 | 1998-05-30 | Diagnosis and treatment of cancer |
Country Status (2)
| Country | Link |
|---|---|
| GB (1) | GB9811598D0 (en) |
| WO (1) | WO1999063110A1 (en) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1320618A (en) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | Polypeptide-human Pax protein 12.5 and polynucleotide for coding it |
| CN1320616A (en) * | 2000-04-27 | 2001-11-07 | 上海博德基因开发有限公司 | Polypeptide-human Pax protein 17 and polynucleotide for coding it |
| CN1321656A (en) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | Novel polypeptide-human Pax protein 11 and polynucleotide for coding this polypeptide |
| CN1321654A (en) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | Novel polypeptide-human pax protein 11.4 and polynucleotide for coding this polypeptide |
| CN1321655A (en) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | Novel polypeptide-human pax protein 10.3 and polynucleotide for coding this polypeptide |
| CN1321664A (en) * | 2000-04-29 | 2001-11-14 | 上海博德基因开发有限公司 | Novel polypeptide-human pax protein 23 and polynucleotide for coding this polypeptide |
| CN1322755A (en) * | 2000-05-09 | 2001-11-21 | 上海博德基因开发有限公司 | New polypeptide human Pax protein 9 and its encoding polynucleotides |
| CN1322752A (en) * | 2000-05-09 | 2001-11-21 | 上海博德基因开发有限公司 | New polypeptide human Pax protein 22 and its encoding polynucleotides |
| EP1352089B1 (en) | 2000-08-25 | 2006-12-06 | Lovelace Respiratory Research Institute | Nested methylation-specific polymerase chain reaction cancer detection method |
| JP2005515787A (en) * | 2001-10-18 | 2005-06-02 | ラブレイス レスピレイトリー リサーチ インスティチュート | Monitoring of cancer by abnormal methylation of promoters of transcription factor genes PAX5α, PAX5β, novel loop helix loop protein, novel gene 2, and beta3 gene |
| EP1361268A1 (en) * | 2002-05-08 | 2003-11-12 | Boehringer Ingelheim International GmbH | Pax-5-deficient pro-B cells, methods of producing them and the use of such cells in human therapy |
| US7217515B2 (en) | 2002-09-30 | 2007-05-15 | Chi Mei Foundation Medical Center | HURP gene as a molecular marker for bladder cancer |
| PH12012502378A1 (en) * | 2010-06-02 | 2013-02-11 | Abraxis Bioscience Llc | Methods of treating bladder cancer |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE4225569C2 (en) * | 1992-08-03 | 1996-04-25 | Max Planck Gesellschaft | Use of a probe for tumor diagnosis or tumor therapy |
-
1998
- 1998-05-30 GB GBGB9811598.3A patent/GB9811598D0/en not_active Ceased
-
1999
- 1999-06-01 WO PCT/GB1999/001720 patent/WO1999063110A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999063110A1 (en) | 1999-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB9903841D0 (en) | Diagnosis and treatment of cancer | |
| HUP9902068A3 (en) | Methods and compositions for the diagnosis and treatment of cancer | |
| IL140845A0 (en) | Compositions for therapy and diagnosis of prostate cancer | |
| GB9824436D0 (en) | Methods of treatment | |
| IL132287A0 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| SI1716853T1 (en) | Treatment of cancers of the human body using ET743 | |
| AU1575697A (en) | Compositions and methods for the treatment and diagnosis of cancer | |
| GB9811598D0 (en) | Diagnosis and treatment of cancer | |
| IL138692A0 (en) | Treatment and prevention of vascular disease | |
| AU2001243349A1 (en) | Methods for the diagnosis and treatment of breast cancer | |
| IL143212A0 (en) | Compositions and methods for the treatment of tumor | |
| IL141426A0 (en) | Compositions and methods for the treatment of tumor | |
| GB9911772D0 (en) | Diagnosis and treatment of atherosclerosis | |
| PL350863A1 (en) | Compositions and methods for the treatment and diagnosis of breast cancer | |
| GB9812550D0 (en) | Tumour therapy and imaging | |
| GB9819999D0 (en) | Treatment of cancer | |
| IL149281A0 (en) | Treatment of cancer | |
| EP1107778A4 (en) | Treatment of disease states | |
| GB9908059D0 (en) | Diagnosis and treatment of diseases | |
| AU6653698A (en) | Use of the p-ten suppressor gene in diagnosis and treatment of cancer | |
| GB2343629B (en) | Treatment of cellulite | |
| GB9606293D0 (en) | Treatment of cancers and other tumours | |
| GB9828564D0 (en) | Materials and methods for the treatment and diagnosis of cancer | |
| AU4005599A (en) | Method for diagnosis and treatment of cancer | |
| GB9423702D0 (en) | Diagnosis and treatment of tumours |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AT | Applications terminated before publication under section 16(1) |